Literature DB >> 27889398

Recognition of Mycobacterial Lipids by Immune Receptors.

Eri Ishikawa1, Daiki Mori1, Sho Yamasaki2.   

Abstract

Mycobacterium tuberculosis (Mtb), the causative agent of tuberculosis (TB), infects one-third of the world's population and causes 1.5 million deaths each year. The cell envelopes of mycobacteria comprise a wealth of unique glycolipids, including trehalose-6,6'-dimycolate (TDM), lipoarabinomannan (LAM), lipomannan (LM), and phosphatidylinositol (PI) mannosides (PIMs). These lipids are important modulators of the host immune responses during infection and in some cases have been used as adjuvants [e.g., complete Freund's adjuvant (CFA)]. Despite this abundant basic knowledge, the identities of the host immune receptors for mycobacterial lipids have long been elusive. Here we review and summarize our current state of knowledge regarding innate immune receptors for mycobacteria, focusing particularly on immunoreceptor tyrosine-based activation motif (ITAM)-coupled C-type lectin receptors (CLRs), which have been shown to recognize mycobacteria-derived glycolipids.
Copyright © 2016 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  C-type lectin receptors; glycolipids; mycobacteria

Mesh:

Substances:

Year:  2016        PMID: 27889398     DOI: 10.1016/j.it.2016.10.009

Source DB:  PubMed          Journal:  Trends Immunol        ISSN: 1471-4906            Impact factor:   16.687


  41 in total

1.  Evaluation of a temperature-restricted, mucosal tuberculosis vaccine in guinea pigs.

Authors:  Tuhina Gupta; Monica LaGatta; Shelly Helms; Rebecca L Pavlicek; Simon O Owino; Kaori Sakamoto; Tamas Nagy; Stephen B Harvey; Mark Papania; Stephanie Ledden; Kevin T Schultz; Candace McCombs; Frederick D Quinn; Russell K Karls
Journal:  Tuberculosis (Edinb)       Date:  2018-10-19       Impact factor: 3.131

Review 2.  Skin microbiota-host interactions.

Authors:  Y Erin Chen; Michael A Fischbach; Yasmine Belkaid
Journal:  Nature       Date:  2018-01-24       Impact factor: 49.962

3.  Mycobacterial trehalose 6,6'-dimycolate induced vascular occlusion is accompanied by subendothelial inflammation.

Authors:  Shen-An Hwang; Caitlan D Byerly; Jeffrey K Actor
Journal:  Tuberculosis (Edinb)       Date:  2019-04-26       Impact factor: 3.131

4.  Mycobacterial Trehalose 6,6'-Dimycolate-Induced M1-Type Inflammation.

Authors:  Thao K T Nguyen; John d'Aigle; Luis Chinea; Zainab Niaz; Robert L Hunter; Shen-An Hwang; Jeffrey K Actor
Journal:  Am J Pathol       Date:  2019-11-14       Impact factor: 4.307

Review 5.  Esx Systems and the Mycobacterial Cell Envelope: What's the Connection?

Authors:  Rachel E Bosserman; Patricia A Champion
Journal:  J Bacteriol       Date:  2017-08-08       Impact factor: 3.490

Review 6.  Mannose-capped lipoarabinomannan in Mycobacterium tuberculosis pathogenesis.

Authors:  Joanne Turner; Jordi B Torrelles
Journal:  Pathog Dis       Date:  2018-06-01       Impact factor: 3.166

7.  The cell envelope-associated phospholipid-binding protein LmeA is required for mannan polymerization in mycobacteria.

Authors:  Kathryn C Rahlwes; Stephanie A Ha; Daisuke Motooka; Jacob A Mayfield; Lisa R Baumoel; Justin N Strickland; Ana P Torres-Ocampo; Shota Nakamura; Yasu S Morita
Journal:  J Biol Chem       Date:  2017-08-29       Impact factor: 5.157

Review 8.  Lipid metabolism and its implication in mycobacteria-host interaction.

Authors:  Gabriela Gago; Lautaro Diacovich; Hugo Gramajo
Journal:  Curr Opin Microbiol       Date:  2017-12-19       Impact factor: 7.934

Review 9.  The knowns and unknowns of latent Mycobacterium tuberculosis infection.

Authors:  W Henry Boom; Ulrich E Schaible; Jacqueline M Achkar
Journal:  J Clin Invest       Date:  2021-02-01       Impact factor: 14.808

Review 10.  Trained immunity as a molecular mechanism for BCG immunotherapy in bladder cancer.

Authors:  Jelmer H van Puffelen; Samuel T Keating; Egbert Oosterwijk; Antoine G van der Heijden; Mihai G Netea; Leo A B Joosten; Sita H Vermeulen
Journal:  Nat Rev Urol       Date:  2020-07-16       Impact factor: 14.432

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.